Adapting, Not Abandoning: The Enduring Importance of Inclusive Clinical Research in a Shifting Landscape

In the ever-evolving landscape of regulatory and political discourse, the focus on diversity, equity, and inclusion (DEI) has experienced considerable shifts. At the US federal level, major policy rollbacks have challenged the prominence and formalization of DEI initiatives. However, within the sphere of clinical research, a distinct counter-narrative is emerging. Clinical research leaders are resolutely reaffirming their commitment to inclusive research, signaling that this imperative remains not just a desirable goal but an essential component of ethical and effective scientific advancement. This unwavering dedication underscores a fundamental understanding: while the language and formal structures around DEI may change, the underlying principles and objectives—ensuring representation, fostering trust, and designing relevant studies—remain paramount.